Данная информация предназначена для специалистов в области здравоохранения и фармацевтики. Пациенты не должны использовать эту информацию в качестве медицинских советов или рекомендаций.
Section 19: Immunologicals
19.1 DIAGNOSTIC AGENTS
tuberculin,3 injection
purified protein derivative (PPD)
¤ Example of a therapeutic group. Various drugs can serve as
alternatives.
3 All tuberculins should comply with the Requirements for
Tuberculins (Revised 1985). WHO Technical Report Series, No.
745, 1987, Annex 1.
Essential Drugs
19.2 SERA AND IMMUNOGLOBULINS 4
anti-D immunoglobulin injection, 250 µg in
(human) single-dose vial
¤antitetanus immunoglobulin injection, 500 IU
(human) in vial
antivenom serum injection
diphtheria antitoxin injection, 10 000 IU,
20 000 IU in vial
immunoglobulin, injection (intramuscular)
human normal (2)
immunoglobulin, injection (intravenous)
human normal (2, 8)
¤rabies immunoglobulin injection, 150 IU/ml
19.3 VACCINES 5
19.3.1 FOR UNIVERSAL IMMUNIZATION
BCG injection
diphtheria injection
pertussis injection
tetanus injection
hepatitis B injection
measles injection
poliomyelitis oral solution
19.3.2 FOR SPECIFIC GROUPS OF INDIVIDUALS
influenza injection
meningitis polysaccharide injection
mumps injection
poliomyelitis, inactivated injection
rabies vaccine (inactivated) injection
prepared in cell culture
rubella injection
typhoid vaccine injection
yellow fever vaccine injection